Royal Melbourne Institute of Technology (RMIT) has announced the launch of the Discovery to Device MedTech Prototyping and Scale-Up Facility (D2D Facility).
The D2D Facility has been established through $12.7 million from the Victorian Government, via the Victorian Higher Education State Investment Fund (VHESIF) Pool 2. It is an advanced facility for prototyping medical devices for wearable, nearable, and diagnostic applications.
The facility is a one-of-a-kind pathway for medical device translation that also strengthens Victoria and Australia’s sovereign capability. It is the only facility of its type in the wider Asia-Pacific region for niche medtech products.
Distinguished Professor Madhu Bhaskaran, Director of the D2D Facility at RMIT, said the facility focused on research translation, turning early-stage ideas into working, testable, investable solutions.
The facility bridges the gap between scientific discovery and product development, enabling rapid prototyping of wearable technologies, diagnostic tools, and biosensors.
It has already lined up industry partners to create several innovations in the medical technology (MedTech) field.
